Comment on

• Comparing encounter-based and annualized chronic pseudomonas infection definitions in cystic fibrosis.

  Rosenfeld M, Faino AV, Onchiri F, Aksit MA, Blackman SM, Blue EE, Collaco JM, Gordon WW, Pace RG, Raraigh KS, Zhou YH, Cutting GR, Knowles MR, Bamshad MJ, Gibson RL. Rosenfeld M, et al. J Cyst Fibros. 2022 Jan;21(1):40-44. doi: 10.1016/j.jcf.2021.07.020. Epub 2021 Aug 13. J Cyst Fibros. 2022. PMID: 34393091
• Longitudinal changes and regional variation of incident infection rates at cystic fibrosis centers, United States 2010-2016.

  Muhlebach MS, Jiang X, Kosorok MR, Klein EY, Saiman L. Muhlebach MS, et al. J Cyst Fibros. 2022 Jan;21(1):34-39. doi: 10.1016/j.jcf.2021.08.009. Epub 2021 Aug 26. J Cyst Fibros. 2022. PMID: 34456157
• Comparison of microbial composition of cough swabs and sputum for pathogen detection in patients with cystic fibrosis.

  Fenn D, Abdel-Aziz MI, Brinkman P, Kos R, Neerincx AH, Altenburg J, Weersink E, Haarman EG, Terheggen-Lagro SWJ, Maitland-van der Zee AH, Bos LDJ; Amsterdam mucociliary clearance disease research group. Fenn D, et al. J Cyst Fibros. 2022 Jan;21(1):52-60. doi: 10.1016/j.jcf.2021.08.031. Epub 2021 Sep 20. J Cyst Fibros. 2022. PMID: 34548223
• Risk factors for Pseudomonas aeruginosa airway infection and lung function decline in children with cystic fibrosis.

  Mésinèle J, Ruffin M, Kemgang A, Guillot L, Boëlle PY, Corvol H. Mésinèle J, et al. J Cyst Fibros. 2022 Jan;21(1):45-51. doi: 10.1016/j.jcf.2021.09.017. Epub 2021 Oct 8. J Cyst Fibros. 2022. PMID: 34629287